Introduction
Thyroid hormone is essential for development and oxidative metabolism in vertebrates. The synthesis of thyroid hormones involves secretion of thyroglobulin (Tg) to the apical extracellular lumen of follicles that serve as the basic functional unit of the thyroid gland. Once secreted, Tg is iodinated via the activity of a thyroid-specific peroxidase to form thyroxine (the major thyroid hormone) involving specific iodinated tyrosyl residues within the Tg polypeptide backbone (1) . No other endogenous proteins of the thyroid are capable of serving as precursors for thyroid hormone synthesis, rendering vertebrate organisms completely dependent on structural information encoded in the Tg molecule -both for directing iodotyrosyl coupling for thyroxine synthesis (2) and for passing ER quality control in the secretory pathway (3) . Cumulatively, steps leading to Tg export from the ER are rate limiting in its overall secretion (4) . Peak secretion of Tg, as measured in cell culture, occurs on the order of 3 hours after synthesis (5) .
The Tg cDNA initially encodes 3 regions referred to collectively as region I-II-III, that span 80% of the full-length Tg monomer (2,746 amino acids in mouse Tg), with each region involving multiple Cys-rich repeat domains covalently "stapled" by intradomain disulfide bonds (6) ; while the final approximately 500 amino acids of Tg are strongly homologous to acetylcholinesterase (7) (8) (9) . The most important site of thyroxine synthesis involves but a small portion of the molecule at the extreme amino terminus of the Tg protein (10, 11) , raising questions about the role of the remaining C-terminal 2,250 amino acids (12) . Indeed, the overall structure of Tg remains unknown; nevertheless, it is clear that along its length, Tg undergoes extensive N-linked glycosylation and monomer folding in the ER (13) .
Congenital hypothyroidism with defective Tg has been reported in species ranging from humans to rats and mice. In all 3 species, the cellular phenotype described includes a dilated ER with induction of ER molecular chaperones (14) , activation of ER stress signaling pathways (15) , and ER-associated degradation (ERAD) of most of the mutant Tg gene product (16) . Of the cases (and animal models) published to date, the cholinesterase-like (ChEL) domain is a very commonly affected site, involving mutations including the newly described A2215D (17, 18) ; R2223H (19) ; G2300D,R2317Q (20) ; G2355V,G2356R; or the skipping of exon 45 (normally encoding 36 residues of the ChEL domain); as well as Q2638Z mutants (where Z represents stop) (21) . In addition are polymorphisms including P2213L and W2482R; and R2511Q that may be associated with an increased incidence of nonmedullary thyroid cancer (22) . Congenital hypothyroidism with defective Tg is caused by the G2300R point mutation localized to the ChEL domain in the rdw/rdw rat dwarf (23, 24) , while we identified L2263P as responsible for the hypothyroidism of the cog/cog congenital goiter mouse (25) . Indeed, a truncated Tg comprising only region I-II-III and lacking the ChEL domain is blocked within the ER (26) . Together, these findings emphasize that in fulllength Tg, a functional ChEL domain is needed to allow Tg to be efficiently transported to the site of thyroid hormone synthesis, in particular, for exit from the ER.
We show in this study, by contrast, that attaching a signal peptide to the ChEL domain is itself sufficient for rapid and efficient intracellular transport of that protein ("secretory ChEL") to the extracellular space. Moreover, by physical association with Tg I-II-III, secretory ChEL rescues in trans maximal protein expression, disulfide maturation, and secretion of Tg I-II-III. Indeed, intentional retention of the functional ChEL domain within the ER, while assisting in Tg I-II-III protein expression and disulfide maturation, prevents its intracellular transport. These data point to both a molecular chaperone and a molecular escort function of the ChEL domain in Tg transport for thyroid hormone synthesis.
Results
Maturation of recombinant Tg. During folding, Tg must bury 122 free Cys thiols into intrachain disulfide bonds. Reactivity with 4-acetamido-4′-maleimidylstilbene-2,2′-disulphonic acid (AMS) irreversibly alkylates available Cys thiols, increasing by 0.5 kDa the protein molecular mass per alkylated Cys (27) , which can ultimately be detected as a molecular mass shift by SDS-PAGE under reducing conditions. Upon denaturation, Tg secreted from cells (which had already passed ER quality control and received Golgi carbohydrate modifications) showed no detectable reactivity with 5 mM AMS (Figure 1, compare lanes 3 and 4) . By contrast, newly synthesized intracellular Tg residing primarily in the ER (5) showed substantial AMS reactivity (compare lanes 5 and 6). Cells treated with brefeldin A (BFA; 5 μg/ml) accumulated in the ER newly synthesized Tg that, in terms of AMS reactivity, seemed equivalent to the sum of secreted and intracellular Tg obtained from untreated cells, revealing the ability to discriminate between distinct folded states. In the case of the rdw mutant bearing the G2300R mutation within the ChEL domain of Tg, none of the Tg molecules in the population appeared able to properly mature, as judged by fact that they buried their Cys thiols (Figure 1 ). By 4% SDS-PAGE, a mobility shift of this magnitude (above that of the 330-kDa Tg band) suggests a molecular mass addition of 10-30 kDa, which might potentially represent modification of as many as 20-60 of the first 116 Cys residues of Tg. By contrast, the ChEL domain bearing the mutation has only 6 Cys residues -even modification of all of these residues would amount to a net molecular mass addition of only 3 kDa, which would not be expected to be seen as a significant mobility shift of the Tg band. Thus, these data imply that a mutation within the ChEL domain may impact on the ability to efficiently form disulfide bonds within upstream Tg region I-II-III, which contain the majority of Tg Cys residues.
Recent studies have shown that for a brief period after synthesis, Tg newly synthesized by thyrocytes can be detected in mixed disulfides with a number of ER oxidoreductases: adducts known as forms A, B, and C that are detected by nonreducing SDS-PAGE (28) . Herein, we used nonreducing SDS-PAGE to examine disulfide maturation of recombinant mouse Tg upon transient expression in 293 cells. For wild-type Tg, adducts in the A, B, and C
Figure 1
Free Cys thiols in Tg. 293 cells were transiently transfected with an expression vector encoding wild-type Tg, the rdw Tg mutant (G2300R), or empty vector. At 48 hours after transfection, cells were pulse labeled for 30 minutes with 35 S-labeled amino acids and chased for 4 hours in the absence or presence of BFA (5 μg/ml) where indicated. At this time, chase media (lanes labeled "Tg secreted") and cell lysates (all other lanes) were immunoprecipitated with anti-Tg. The immunoprecipitates were denatured in 2× SDS gel sample buffer lacking reducing agents and mock incubated or incubated with AMS (5 mM, 30°C for 1 hour). At the end of the incubation, samples were boiled in the presence of 20 mM DTT and analyzed by 4% SDS-PAGE and fluorography. A slowed mobility (shift up) of the Tg band after AMS is indicative of free reactive thiols in the Tg molecule that are not apparent in secreted, wild-type Tg. Using PC Cl3 thyrocytes expressing endogenous Tg, we found that the newly identified E isoform is essentially identical to that secreted to the medium. What confounds the nonreducing SDS-PAGE analysis of Tg band mobility is the presence of Golgimodified N-linked glycans on Tg ( Figure 3A , right panel). Thus, a comparison of band mobility upon nonreducing SDS-PAGE can be made only after treatment with PNGase F to remove all N-linked oligosaccharides ( Figure 3A , left panel; a double-headed arrow establishes the identity of the E isoform in cells and media). Similar results were obtained for recombinant Tg expressed in 293 cells when examined without ( Figure 3B ) or with ( Figure 3C ) prior PNGase F digestion.
Tg monomer folding is temperature dependent (29) , and Tg secretion is profoundly inhibited at both 20°C and 25°C. At 25°C, there was a slight increase in Tg adducts A, B, and C at the 0 chase time ( With these results serving as positive controls for Tg folding, we proceeded to examine the oxidative maturation of both cog Tg and rdw Tg (which bear mutations in the ChEL domain). As shown in Figure  2C , these proteins, even at 2 hours after synthesis, appeared arrested as early folding intermediates, including both Tg adducts and the incompletely oxidized D isoform. While we do not yet know the specific Tg Cys residues involved in either adduct formation or maturation from D to E forms, these data further imply that function of the ChEL domain is crucial to global folding of the Tg molecule.
The isolated ChEL domain folds autonomously in the secretory pathway. The Tg ChEL domain exhibits substantial primary sequence simi-
Figure 3
Oxidation state of secreted Tg. At each chase time, cells were lysed in buffer including 20 mM N-ethylmaleimide, and the lysates and chase media immunoprecipitated with anti-Tg and analyzed by nonreducing 4% SDS-PAGE and fluorography. (A) PC Cl3 cells were pulse labeled for 10 minutes with 35 S-labeled amino acids and then chased for the times indicated. Immunoprecipitates were either undigested or digested with PNGase F as indicated. Folding intermediates A, B, and C, which have been characterized in previous studies (28) , are shown. Also identifed are 2 closely spaced Tg disulfide isomer bands labeled D and E, respectively. Because of glycosylation differences, the mature E isoform does not comigrate with Tg secreted to the medium at 1 hour of chasing. After PNGase F digestion to remove N-glycans, all Tg forms exhibit a faster (shifted-down) mobility. Under these conditions, it is now apparent that secreted Tg comigrates with the intracellular E isomer, identifying the most oxidized band as the most mature folded form of Tg. 
Figure 4
Efficient exit of the isolated Tg ChEL domain from the ER. 293 cells were transiently transfected with a plasmid encoding the wild-type mouse Tg ChEL domain preceded by the prolactin signal peptide (Secretory ChEL) or were untransfected (293 control). Cells were pulse labeled for 30 minutes with 35 S-labeled amino acids and chased for 0 or 4 hours as indicated, at which time the cells were lysed and both lysates and media immunoprecipitated with a rabbit polyclonal anti-Tg. Immunoprecipitates from transfected cells were divided in 2 equal portions and either mock digested or digested with endoglycosidase H (Endo H). Finally, all samples were analyzed by reducing 5.5% SDS-PAGE and fluorography. The band shift observed after digestion of secretory ChEL from the 0 chase time (shift down, lane 2) is indicative of endoglycosidase H sensitivity and defines ChEL that has not yet reached the Golgi complex; in contrast, none of the secreted ChEL shows the same endoglycosidase H sensitivity, indicating intracellular transport via the Golgi complex. The lanes shown were all run on the same gel, although they are presented noncontiguously. The position of the 76-kDa molecular mass standard is shown at left. larity with authentic acetylcholinesterase, a well-studied protein (30) that is fully competent for intracellular transport to the cell surface. We therefore attempted to examine secretory behavior of the isolated ChEL domain driven into the ER via an artificial (prolactin) signal peptide. Indeed, within 4 hours after synthesis, the recombinant secretory ChEL protein was nearly completely released from cells as an endoglycosidase H-resistant species (Figure 4 , lane 6), indicating that it traversed the intracellular transport pathway as a normal secretory protein.
The ChEL domain is an intramolecular chaperone for Tg region I-II-III. We previously reported that Tg region I-II-III is secretion incompetent (26) . To confirm this point, we followed the secretion and sensitivity to endoglycosidase H digestion of newly synthesized I-II-III 4 hours after synthesis. Indeed, while full-length wild-type Tg was efficiently secreted, I-II-III remained intracellular ( Figure  5A ). Persistence of sensitivity to endoglycosidase H digestion (Figure 5B) indicated that I-II-III does not have sufficient information for efficient intracellular transport. This was also true even at extended chase times ( Figure 5C , upper panel). These data support our previous hypothesis that the ChEL domain may be required for normal conformational maturation and intracellular transport of Tg (26) .
To better understand the relationship of the I-II-III domains to the ChEL domain, we coexpressed these as separate proteins within the ER. Remarkably, in trans, presence of the secretory ChEL domain in the ER rescued the export of I-II-III. This secretion was progressive over time ( Figure 5C , lower panels).
A likely implication of these findings is that I-II-III directly interacts with the ChEL domain. To examine this, we constructed a secretory ChEL with a carboxyterminal myc-epitope tag. Then either secretory ChEL or secretory ChEL-myc was coexpressed with I-II-III in 293 cells. After metabolic labeling, the chase medium bathing these cells was collected and evenly divided for immunoprecipitation with either anti-Tg or anti-myc ( Figure  6A ). Anti-Tg (lanes 1-3) directly immunoprecipitated both secretory ChEL (or ChEL-myc) as well as the rescued cosecreted I-II-III. Anti-myc (lanes 4-6) could not immunoprecipitate untagged ChEL and also failed to recover any I-II-III. However, anti-myc immunoprecipitated secretory ChEL-myc and quantitatively coprecipitated all of the I-II-III ( Figure 6A , lane 6) that could be directly immunoprecipitated with polyclonal anti-Tg (lane 3).
These data strongly suggest that nearly 100% of secreted I-II-III associates with secretory ChEL within the ER and remains associated throughout the secretory pathway. Yet newly synthesized I-II-III is secreted with much slower kinetics than the cohort of labeled ChEL molecules synthesized at the same time ( Figure 5C ). I-II-III secretion must be dependent upon subsequently synthesized ChEL molecules, as post-pulse inhibition of further protein synthesis with cycloheximide ( Figure 6B, lanes 3 and 4) blocked secretion of newly synthesized I-II-III even as it had no effect on the secretion of labeled ChEL. Thus, I-II-III is not ready to interact with ChEL when I-II-III is first made but evidently needs preliminary folding to acquire competence for ChEL interaction. By contrast, ChEL export can proceed independently of I-II-III (Figure 4) , decreasing its availability in the ER, which may limit efficiency of I-II-III transport ( Figure 5C ). To test this, we performed cotransfections of cDNAs encoding I-II-III and secretory ChEL at different plasmid ratios (with I-II-III cDNA and total DNA per transfection held constant). As shown in Figure 7A , increasing secretory ChEL cDNA increased the expression and secretion of the ChEL protein (bottom panel). Simultaneously, this also increased the quantity of I-II-III that was recovered intracellularly after a 6-hour chase, despite the fact that the transfection quantity of I-II-III cDNA was held constant (upper panel). As the initially synthesized I-II-III (0 chase time) was only marginally affected by coexpression of secretory ChEL ( Figure 7B ), it appears that most of the intracellular increase in I-II-III protein reflects stabilization after synthesis. Indeed, we determined that total I-II-III recovery was increased 100% (i.e., doubled) at 16 hours of chase when secretory ChEL was expressed compared with vector DNA alone ( Figure 7B ). 
Figure 7
ChEL interaction improves recovery as well as secretion of Tg I-II-III. (A) 293 cells were triply transfected with empty vector plus a plasmid encoding Tg region I-II-III (always 0.1 μg DNA per well) plus a plasmid encoding the secretory ChEL domain (at different DNA levels as shown). DNA in each transfection totaled 3.1 μg per well. Transfected cells were pulse labeled for 30 minutes with 35 S-labeled amino acids and chased for 6 hours, at which time the cells were lysed, and both lysates and media were immunoprecipitated with anti-Tg and analyzed by reducing 5.5% SDS-PAGE and fluorography, as shown. The position of a 76-kDa molecular mass marker is shown at left. The figure has been spliced at the position indicated by a black line (between lanes 2 and 3), but all data were derived from a single exposure of the same gel. (B) Cells were either untransfected or transfected with 0.5 μg plasmid DNA encoding I-II-III plus 2.5 μg of vector DNA or that encoding secretory ChEL. As a positive control, 2 μg of plasmid DNA encoding wild-type Tg was transfected in parallel. Cells were pulse labeled for 30 minutes with 35 S-labeled amino acids and chased for either 0 or 16 hours, at which time the cells were lysed and both lysates and media immunoprecipitated with anti-Tg and analyzed by reducing 5.5% SDS-PAGE and phosphorimaging, as shown. The intracellular band density at the 0 chase time was defined as 100%; based on this, the recovery of each band at 16 hours is shown. Total recovery of labeled I-II-III alone at 16 hours was approximately 35%, while total recovery of labeled I-II-III (cells plus media) in the presence of secretory ChEL was approximately 68%.
Accompanying the increased recovery in I-II-III was an increase in the amount of I-II-III secretion ( Figure 7A) .
If the ChEL domain were acting as a molecular chaperone for I-II-III, we reasoned that secretory ChEL might be able to enhance oxidative folding of I-II-III. To test this, we designed a secretory ChEL-KDEL construct, in which the KDEL sequence retains the ChEL domain in the early secretory pathway (discussed below). In a pulse-chase format, presence of the ChEL-KDEL protein promoted disulfide maturation of I-II-III from an incompletely oxidized intermediate (reminiscent of intermediate D of full-length Tg; see Figure 2 ) to a more mature (E-like) form ( Figure 8A, arrows) . To determine whether ChEL domain tertiary structure is required for oxidative rescue of I-II-III, we compared the ChEL-KDEL construct with other secretory ChEL constructs bearing cog or rdw mutations, which are also retained within the early secretory pathway. As shown in Figure 8B , unlike ChEL-KDEL, these mutations within the ChEL domain had little or no beneficial effect on oxidative maturation of I-II-III. By contrast, authentic secretory ChEL (without KDEL) promoted secretion of I-II-III protein that, after deglycosylation with PNGase F, exhibited oxidative maturation comparable to that of the mature E form seen intracellularly ( Figure 9) . Together, the data in Figures 8 and 9 strongly suggest that a native ChEL domain acts like an intramolecular chaperone, facilitating oxidative maturation of upstream Tg domains.
The ChEL domain is a molecular escort for Tg region I-II-III. If the ChEL domain serves only as a true molecular chaperone within Tg, then we would expect that when expressed in trans, secretory ChEL (like other molecular chaperones) would show a binding preference for early I-II-III folding intermediates over fully mature molecules. To examine this, we coimmunoprecipitated intracellular I-II-III with secretory ChEL-myc in cells treated with BFA to block intracellular transport in the secretory pathway. In the absence of ChEL, I-II-III exhibited defective oxidative maturation ( Figure 10, lanes 2-4) , while in the presence of secretory ChEL-myc, anti-Tg directly and efficiently immunoprecipitated both immature D and mature E forms of I-II-III (lanes 5-7) . The presence of ChEL appeared to increase recovery of I-II-III, consistent with results shown in Figure 7 . By contrast, the immunoprecipitation of ChEL with anti-myc seemed inefficient at coprecipitation of the unfolded I-II-III isomer, as compared with the efficient recovery of the faster-migrating, mature I-II-III (Figure 10, lanes 9 and 10) . These data along with the persistent ChEL association with I-II-III even after secretion ( Figure 6A ) indicate that ChEL serves as more than an intramolecular chaperone for unfolded Tg molecules. If indeed the ChEL domain helps to physically convey I-II-III export from the ER, then if ChEL transport were to be disrupted, I-II-III transport would be disrupted in parallel. This proved to be the case, as unlike secretory ChEL, secretory ChEL-KDEL permitted secretion of I-II-III only to the extent that the ChEL-KDEL itself escaped from the cells (Figure 11, A and B) , despite the fact that ChEL-KDEL facilitated the oxidative maturation of I-II-III (Figure 8) . As predicted by results in Figure 8B , secretory ChEL bearing cog or rdw mutations also did not support I-II-III secretion ( Figure  11B ), just as these mutations do not permit secretion of intact Tg. Together, the data indicate that the ChEL domain functions as both an intramolecular chaperone and molecular escort for Tg maturation and transport in the secretory pathway.
Discussion
Tg has evolved as the unique protein precursor for thyroid hormone synthesis. Specially encoded structural features for thyroid hormone formation and iodide storage (2) are known to come into play once the Tg molecule has been delivered extracellularly, where it comes in contact with the thyroidal iodination machinery (31) . However, structural features encoding Tg transport in the secretory pathway -required for Tg to serve as a prohormone -have 
Figure 9
Oxidation state of secreted I-II-III. 293 cells were transfected either with empty vector (control) or with secretory ChEL bearing or lacking the KDEL appendage. The cells were pulse labeled for 30 min with 35 Slabeled amino acids and then chased for the times indicated (control cells were chased for 2 hours). The cells were lysed, and both lysates and chase medium immunoprecipitated with anti-Tg and subjected to PNGase F digestion to remove N-glycans. The samples were then analyzed by nonreducing 5.5% SDS-PAGE. Under these conditions, it is apparent that secreted I-II-III closely migrates with the intracellular E isomer of I-II-III. A black line has been added to distinguish the medium from the cell lysate. The position of a 176-kDa molecular mass marker is shown at left. been more elusive. In spite of this, it appears that most congenital hypothyroidism with deficient Tg is caused by mutations in which intracellular Tg transport is blocked, rather than by defects in the ability to synthesize thyroid hormone per se (1, 32) . Evolutionary pressure definitely exists for Tg to be maintained as a secreted protein, as its inability to do so (at least in Merino sheep) compromises viability to a stage where animals cannot reach reproductive age (33, 34) . We now present what we believe to be the first evidence directly implicating the ChEL domain in assisting the intracellular protein transport of Tg.
One way in which the ChEL domain may participate in Tg export is by facilitating Tg folding. We previously suspected that ChEL forms an independently folded domain within Tg, because its replacement by authentic acetylcholinesterase results in a chimera with active cholinesterase function (26) . Yet single point mutations in the ChEL region appear sufficient to prevent formation of disulfide bonds that are made in upstream Tg regions, as evidenced not only by remarkable reactivity with AMS (Figure 1 ), but also by direct assessment of global disulfide maturation (with cog and rdw mutants being trapped in partially oxidized folding intermediates; Figure 2 ). Using a cleavable signal peptide, we now find that the isolated ChEL domain is a very effective secretory protein in its own right (Figure 4) , whereas I-II-III alone cannot escape ER retention ( Figure 5, A and B) . The simplest hypothesis (still to be tested) is that exposed chaperone-binding regions on Tg I-II-III confers its ER retention. Remarkably, our current evidence supports that the presence of the ChEL domain in the ER enriches for an oxidatively mature form of I-II-III (Figure 8 ), increases intracellular recovery of I-II-III (Figures 7 and 10) , and allows I-II-III to be secreted ( Figure  5C ) in a form that is both endoglycosidase H resistant (data not shown) and appropriately oxidized ( Figure 9 ). Thus, we propose that as long as the ChEL domain is itself properly folded ( Figure  11B ), it functions as an intramolecular chaperone within the context of full-length Tg, facilitating the efficiency of "on-pathway" protein folding, leading to ER exit.
However, this does not appear to be the whole story, because the ChEL domain is transported with Tg out of the ER. Surprisingly, this is not simply because the ChEL domain is physically contigu-
Figure 10
Intracellular association of secretory ChEL with I-II-III. 293 cells were transfected with empty vector or with plasmid DNAs encoding I-II-III (0.5 μg) plus 1.5 μg of either vector alone (I-II-III) or secretory ChEL with an appended myc epitope tag (ChEL-myc). All cells were pulse labeled for 30 minutes with 35 S-labeled amino acids and chased for the times shown in the presence of BFA (5 μg/ml). The cells were lysed and immunoprecipitated either anti-Tg (lanes 1-7) or anti-myc (lanes 8-11). Immunoprecipitates were analyzed by nonreducing 5.5% SDS-PAGE and fluorography, with the I-II-III region shown. The I-II-III band seen at time 0 appears equivalent to that of the D isoform, while ChELmyc favorably coprecipitates a faster-migrating band equivalent to that of the mature E isoform (arrow). The position of a 176-kDa molecular mass marker is shown at left.
Figure 11
The Tg ChEL domain functions as a molecular escort. ous within the Tg protein. Indeed, secretory ChEL, made as a separate protein, is engaged in a direct physical interaction with I-II-III throughout the secretory pathway and into the extracellular space ( Figure 6A ). Nevertheless, most newly synthesized I-II-III does not exit the ER with a secretory ChEL partner that was synthesized during the same pulse-labeling period. Rather, the kinetics of I-II-III secretion are delayed in comparison to the speedy (and efficient) release of coexpressed secretory ChEL ( Figure 5C ). Evidently, intracellular transport of I-II-III must wait for subsequently translated ChEL domain to become available for interaction ( Figure 6B) . Thus, in all likelihood, I-II-III must undergo some preliminary folding prior to its interaction with ChEL. Indeed, the ChEL domain has an even stronger affinity for well-folded I-II-III than it does for immature I-II-III (Figure 10 ). This binding is not accidental but essential to the Tg secretory process. Specifically, retention of ChEL within the ER-Golgi system via an engineered KDEL sequence co-retains the mature I-II-III ( Figure 11 ) -even as it permits the ChEL domain to function normally as a molecular chaperone (Figure 8 ). Thus, we are forced to conclude that the ChEL domain also functions as a molecular escort (3) required to convey Tg I-II-III out of the ER.
It is interesting to consider the evolutionary dependence of Tg on these mechanisms of intramolecular rescue, given that the major thyroid hormone-forming site in Tg is at its extreme amino terminus (35) . One might predict that a highly truncated Tg with fewer disulfide bonds and preservation of crucial amino acids for thyroid hormone formation (10, 11) would allow survival without the need of intramolecular chaperone or escort functions. Indeed, there is speculation that such a short aminoterminal portion of Tg may be all that is required for human survival, which requires ongoing thyroid hormone synthesis (36) . However, evolutionary and environmental circumstances (i.e., iodide unavailability on the earth's crust) have promoted development of a more complex Tg structure for iodide storage in vertebrate organisms (1) .
In summary, we propose that intracellular Tg transport for thyroid hormone synthesis is dependent on intramolecular chaperone and escort functions embedded within its ChEL domain.
Methods
Materials. AMS, Lipofectamine 2000, FBS, penicillin, and streptomycin were from Invitrogen; Complete Protease Inhibitor Cocktail was from Roche; BFA, protein G-agarose, and protein A-agarose were from Sigma-Aldrich; endoglycosidase H was from New England Biolabs Inc.; Trans 35 S-Label was from MP Biomedicals; Zysorbin was from Zymed Laboratories Inc. (Invitrogen); TransIT-LT1 Transfection Reagent was from Mirus. Rabbit polyclonal antimyc was from Immunology Consultants Laboratory Inc. and monoclonal anti-acetylcholinesterase (MAB303) was from Millipore. Rabbit polyclonal anti-Tg (containing antibodies against epitopes at both N-and C-terminal regions of the protein) has been previously described (14) .
Site-directed mutagenesis of mouse Tg cDNA. ChEL domain mutations were introduced with the QuikChange Site-Directed Mutagenesis Kit (Stratagene) using the following mutagenic primers: ChEL-KDEL (5′-GCCT-GTCCCCAAGAGCTACAGCAAAGACGAGCTATAGGCCGCTTCCCTT-TAGTGAGGG-3′ and 5′-CCCTCACTAAAGGGAAGCGGCCTATAGCTC-G T C T T T G C T G T AG C T C T T G G G G A C A G G C -3 ′ ) ; C h E L -m y c (5′-CAAGAGCTACAGCAAAGAACAGAAACTGATCTCTGAGGAGGACT-TATGATTAATGCTTCG-3′ and 5′-CGAAGCATTAATCATAAGTCCTCCT-CAGAGATCAGTTTCTGTTCTTTGCTGTAGCTCTTG-3′). The truncated Tg region I-II-III was made by introducing a stop codon at L2169 (5′-GGAAGTCTGGAATCCCTTAGGTCCAATCTGATGTAACATCC-3′ and 5′-GGATGTTACATCAGATTGGACCTAAGGGATTCCAGACTTCC-3′) within Tg subcloned into pCMS (BD Biosciences -Clontech). To make the secretory ChEL domain, a Sal I restriction site was introduced into the 5′ end of ChEL by using a pair of mutagenesis primers (5′-CCTACATC-TACCGGAAGTCTGGTCGACCTTTGGTCCAATCTGATGTAACATCC-3′ and 5′-GGATGTTACATCAGATTGGACCAAAGGTCGACCAGACTTCCG-GTAGATGTAGG-3′) with subcloning into the SalI and NotI sites of pCMS. Each mutation was confirmed by direct cDNA sequencing before expression in 293 cells. The prolactin signal peptide in pSPPS1 (a kind gift from V. Lingappa, UCSF, San Francisco, California, USA) was fused in frame at the 5′ end of the ChEL cDNA using NheI and SalI sites.
Cell culture and transfection. 293 cells were cultured in DMEM with 10% FBS in 6-well plates at 37°C in a humidified 5% CO2 incubator. Plasmids were transiently transfected using TransIT-LT1 or Lipofectamine 2000 transfection reagent according to the manufacturer's instructions.
Metabolic labeling and immunoprecipitation. Transfected 293 cells were starved for 30 minutes in Met/Cys-free DMEM, then pulse labeled with 180 μCi/ml 35 S-labeled amino acids for 30 minutes. The cells were then washed with an excess of cold Met/Cys and chased in complete DMEM. At each time point, cells were lysed in buffer containing 1% NP-40, 0.1% SDS, 0.1 M NaCl, 2 mM EDTA, 25 mM Tris pH 7.4, and protease inhibitor cocktail (for cells expressing authentic acetylcholinesterase, lysis buffer contained 1% Triton X-100, 0.1 M NaCl, 2 mM EDTA, 25 mM Tris pH 7.4, and protease inhibitors). Where indicated, 20 mM N-ethylmaleimide was also added to the lysis buffer. For immunoprecipitation, anti-Tg or anti-acetylcholinesterase antibodies were incubated with cell or media samples overnight at 4°C, and the immunoprecipitate was recovered with protein Aagarose (for anti-Tg) or protein G-agarose (for anti-acetylcholinesterase). For coimmunoprecipitation studies, samples were incubated overnight at 4°C with anti-myc antibodies and protein A-agarose. Immunoprecipitates (or coprecipitates) were washed 3 times before being boiled in SDS sample buffer with or without reducing agent, resolved by SDS-PAGE, and analyzed by fluorography or phosphorimaging.
Alkylation of Tg Cys thiols. Immunoprecipitated Tg was resuspended and incubated in a buffer containing 2% SDS, 50 mM Tris pH 7.4 with or without 5 mM AMS for 1 hour at 30°C. The reaction was stopped by boiling in SDS sample buffer plus 0.1 M DTT before analysis by SDS-PAGE.
Endoglycosidase H digestion. Immunoprecipitates were boiled for 10 minutes in 0.5% SDS containing 1% 2-mercaptoethanol in 20 mM Tris pH 7.4 and digested with 250 U of endoglycosidase H in 50 mM sodium citrate, pH 5.5, for 1 hour at 37°C.
